{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T13:27:46Z","timestamp":1783344466857,"version":"3.54.6"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T00:00:00Z","timestamp":1484524800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1038\/npp.2017.10","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T12:29:51Z","timestamp":1484569791000},"page":"1776-1788","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial"],"prefix":"10.1038","volume":"42","author":[{"given":"Lara A","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spencer","family":"Bujarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Shoptaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel JO","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Heinzerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Miotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,16]]},"reference":[{"key":"BFnpp201710_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11481-009-9185-z","volume":"5","author":"RN Achur","year":"2010","unstructured":"Achur RN, Freeman WM, Vrana KE (2010). Circulating cytokines as biomarkers of alcohol abuse and alcoholism. J Neuroimmune Pharmacol 5: 83\u201391.","journal-title":"J Neuroimmune Pharmacol"},{"key":"BFnpp201710_CR2","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/adb.12028","volume":"19","author":"S Ahmadiantehrani","year":"2014","unstructured":"Ahmadiantehrani S, Barak S, Ron D (2014). GDNF is a novel ethanol-responsive gene in the VTA: implications for the development and persistence of excessive drinking. Addict Biol 19: 623\u2013633.","journal-title":"Addict Biol"},{"key":"BFnpp201710_CR3","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrn812","volume":"3","author":"MS Airaksinen","year":"2002","unstructured":"Airaksinen MS, Saarma M (2002). The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3: 383\u2013394.","journal-title":"Nat Rev Neurosci"},{"key":"BFnpp201710_CR4","doi-asserted-by":"publisher","first-page":"8285","DOI":"10.1523\/JNEUROSCI.0976-10.2010","volume":"30","author":"S Alfonso-Loeches","year":"2010","unstructured":"Alfonso-Loeches S, Pascual-Lucas M, Blanco AM, Sanchez-Vera I, Guerri C (2010). Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage. J Neurosci 30: 8285\u20138295.","journal-title":"J Neurosci"},{"key":"BFnpp201710_CR5","doi-asserted-by":"publisher","first-page":"11347","DOI":"10.1073\/pnas.89.23.11347","volume":"89","author":"CA Altar","year":"1992","unstructured":"Altar CA, Boylan CB, Jackson C, Hershenson S, Miller J, Wiegand SJ et al (1992). Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc Natl Acad Sci USA 89: 11347\u201311351.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp201710_CR6","doi-asserted-by":"publisher","first-page":"9885","DOI":"10.1523\/JNEUROSCI.1750-11.2011","volume":"31","author":"S Barak","year":"2011","unstructured":"Barak S, Carnicella S, Yowell QV, Ron D (2011). Glial cell line-derived neurotrophic factor reverses alcohol-induced allostasis of the mesolimbic dopaminergic system: implications for alcohol reward and seeking. J Neurosci 31: 9885\u20139894.","journal-title":"J Neurosci"},{"key":"BFnpp201710_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/adb.12152","volume":"20","author":"S Barak","year":"2015","unstructured":"Barak S, Wang J, Ahmadiantehrani S, Ben Hamida S, Kells AP, Forsayeth J et al (2015). Glial cell line-derived neurotrophic factor (GDNF) is an endogenous protector in the mesolimbic system against excessive alcohol consumption and relapse. Addict Biol 20: 629\u2013642.","journal-title":"Addict Biol"},{"key":"BFnpp201710_CR8","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0022-3565(25)09664-8","volume":"273","author":"MS Barnette","year":"1995","unstructured":"Barnette MS, Grous M, Cieslinski LB, Burman M, Christensen SB, Torphy TJ (1995). Inhibitors of phosphodiesterase IV (PDE IV) increase acid secretion in rabbit isolated gastric glands: correlation between function and interaction with a high-affinity rolipram binding site. J Pharmacol Exp Ther 273: 1396\u20131402.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp201710_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ejphar.2010.04.010","volume":"637","author":"PM Beardsley","year":"2010","unstructured":"Beardsley PM, Shelton KL, Hendrick E, Johnson KW (2010). The glial cell modulator and phosphodiesterase inhibitor, AV411 (ibudilast), attenuates prime- and stress-induced methamphetamine relapse. Eur J Pharmacol 637: 102\u2013108.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp201710_CR10","volume-title":"Beck Anxiety Inventory Manual","author":"AT Beck","year":"1993","unstructured":"Beck AT, Steer RA Beck Anxiety Inventory Manual. Psychological Corporation: San Antonio, TX; (1993)."},{"key":"BFnpp201710_CR11","volume-title":"Manual for the Beck Depression Inventory-II","author":"AT Beck","year":"1996","unstructured":"Beck AT, Steer RA, Brown GK Manual for the Beck Depression Inventory-II. Psychological Corporation: San Antonio, TX; (1996)."},{"key":"BFnpp201710_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/adb.12106","volume":"20","author":"RL Bell","year":"2015","unstructured":"Bell RL, Lopez MF, Cui C, Egli M, Johnson KW, Franklin KM et al (2015). Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence. Addict Biol 20: 38\u201342.","journal-title":"Addict Biol"},{"key":"BFnpp201710_CR13","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.2105\/AJPH.2007.124537","volume":"98","author":"JA Berlin","year":"2008","unstructured":"Berlin JA, Glasser SC, Ellenberg SS (2008). Adverse event detection in drug development: recommendations and obligations beyond phase 3. Am J Public Health 98: 1366\u20131371.","journal-title":"Am J Public Health"},{"key":"BFnpp201710_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.drugalcdep.2011.10.018","volume":"123","author":"GE Bigelow","year":"2012","unstructured":"Bigelow GE, Preston KL, Schmittner J, Dong Q, Gastfriend DR (2012). Opioid challenge evaluation of blockade by extended-release naltrexone in opioid-abusing adults: dose-effects and time-course. Drug Alcohol Depend 123: 57\u201365.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp201710_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fnins.2014.00129","volume":"8","author":"YA Blednov","year":"2014","unstructured":"Blednov YA, Benavidez JM, Black M, Harris RA (2014). Inhibition of phosphodiesterase 4 reduces ethanol intake and preference in C57BL\/6J mice. Front Neurosci 8: 129.","journal-title":"Front Neurosci"},{"key":"BFnpp201710_CR16","doi-asserted-by":"publisher","first-page":"S92","DOI":"10.1016\/j.bbi.2011.01.008","volume":"25","author":"YA Blednov","year":"2011","unstructured":"Blednov YA, Benavidez JM, Geil C, Perra S, Morikawa H, Harris RA (2011). Activation of inflammatory signaling by lipopolysaccharide produces a prolonged increase of voluntary alcohol intake in mice. Brain Behav Immun 25: S92\u2013S105.","journal-title":"Brain Behav Immun"},{"key":"BFnpp201710_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1369-1600.2010.00284.x","volume":"17","author":"YA Blednov","year":"2012","unstructured":"Blednov YA, Ponomarev I, Geil C, Bergeson S, Koob GF, Harris RA (2012). Neuroimmune regulation of alcohol consumption: behavioral validation of genes obtained from genomic studies. Addict Biol 17: 108\u2013120.","journal-title":"Addict Biol"},{"key":"BFnpp201710_CR18","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1530-0277.1995.tb01554.x","volume":"19","author":"MJ Bohn","year":"1995","unstructured":"Bohn MJ, Krahn DD, Staehler BA (1995). Development and initial validation of a measure of drinking urges in abstinent alcoholics. Alcohol Clin Exp Res 19: 600\u2013606.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201710_CR19","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1183\/09031936.93.05080982","volume":"5","author":"T Brunnee","year":"1992","unstructured":"Brunnee T, Engelstatter R, Steinijans VW, Kunkel G (1992). Bronchodilatory effect of inhaled zardaverine, a phosphodiesterase III and IV inhibitor, in patients with asthma. Eur Respir J 5: 982\u2013985.","journal-title":"Eur Respir J"},{"key":"BFnpp201710_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.15288\/jsa.1994.55.149","volume":"55","author":"KK Bucholz","year":"1994","unstructured":"Bucholz KK, Cadoret R, Cloninger CR, Dinwiddie SH, Hesselbrock VM, Nurnberger JI Jr et al (1994). A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J Stud Alcohol 55: 149\u2013158.","journal-title":"J Stud Alcohol"},{"key":"BFnpp201710_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.brat.2016.05.008","volume":"86","author":"S Bujarski","year":"2016","unstructured":"Bujarski S, Ray LA (2016). Experimental psychopathology paradigms for alcohol use disorders: applications for translational research. Behav Res Ther 86: 11\u201322.","journal-title":"Behav Res Ther"},{"key":"BFnpp201710_CR22","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/nri1200","volume":"3","author":"T Calandra","year":"2003","unstructured":"Calandra T, Roger T (2003). Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3: 791\u2013800.","journal-title":"Nat Rev Immunol"},{"key":"BFnpp201710_CR23","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1111\/j.1530-0277.2009.00922.x","volume":"33","author":"S Carnicella","year":"2009","unstructured":"Carnicella S, Ahmadiantehrani S, Janak PH, Ron D (2009a). GDNF is an endogenous negative regulator of ethanol-mediated reward and of ethanol consumption after a period of abstinence. Alcohol Clin Exp Res 33: 1012\u20131024.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201710_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.alcohol.2008.12.001","volume":"43","author":"S Carnicella","year":"2009","unstructured":"Carnicella S, Amamoto R, Ron D (2009b). Excessive alcohol consumption is blocked by glial cell line-derived neurotrophic factor. Alcohol 43: 35\u201343.","journal-title":"Alcohol"},{"key":"BFnpp201710_CR25","doi-asserted-by":"publisher","first-page":"8114","DOI":"10.1073\/pnas.0711755105","volume":"105","author":"S Carnicella","year":"2008","unstructured":"Carnicella S, Kharazia V, Jeanblanc J, Janak PH, Ron D (2008). GDNF is a fast-acting potent inhibitor of alcohol consumption and relapse. Proc Natl Acad Sci USA 105: 8114\u20138119.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp201710_CR26","doi-asserted-by":"publisher","first-page":"11313","DOI":"10.1073\/pnas.1002716107","volume":"107","author":"Y Cho","year":"2010","unstructured":"Cho Y, Crichlow GV, Vermeire JJ, Leng L, Du X, Hodsdon ME et al (2010a). Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast. Proc Natl Acad Sci USA 107: 11313\u201311318.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp201710_CR27","doi-asserted-by":"publisher","first-page":"11313","DOI":"10.1073\/pnas.1002716107","volume":"107","author":"Y Cho","year":"2010","unstructured":"Cho Y, Crichlow GV, Vermeire JJ, Leng L, Du X, Hodsdon ME et al (2010b). Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast. Proc Natl Acad Sci USA 107: 11313\u201311318.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp201710_CR28","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1038\/npp.2013.143","volume":"38","author":"SD Comer","year":"2013","unstructured":"Comer SD, Mogali S, Saccone PA, Askalsky P, Martinez D, Walker EA et al (2013). Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers. Neuropsychopharmacology 38: 2427\u20132438.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201710_CR29","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1111\/adb.12261","volume":"21","author":"ZD Cooper","year":"2015","unstructured":"Cooper ZD, Johnson KW, Pavlicova M, Glass A, Vosburg SK, Sullivan MA et al (2015). The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers. Addict Biol 21: 895\u2013903.","journal-title":"Addict Biol"},{"key":"BFnpp201710_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1021\/jm9505066","volume":"39","author":"AJ Duplantier","year":"1996","unstructured":"Duplantier AJ, Biggers MS, Chambers RJ, Cheng JB, Cooper K, Damon DB et al (1996). Biarylcarboxylic acids and -amides: inhibition of phosphodiesterase type IV versus [3H]rolipram binding activity and their relationship to emetic behavior in the ferret. J Med Chem 39: 120\u2013125.","journal-title":"J Med Chem"},{"key":"BFnpp201710_CR31","doi-asserted-by":"publisher","first-page":"444","DOI":"10.15288\/jsa.1995.56.444","volume":"56","author":"J Erblich","year":"1995","unstructured":"Erblich J, Earleywine M (1995). Distraction does not impair memory during intoxication: support for the attention-allocation model. J Stud Alcohol 56: 444\u2013448.","journal-title":"J Stud Alcohol"},{"key":"BFnpp201710_CR32","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1111\/j.1530-0277.1999.tb04349.x","volume":"23","author":"BA Flannery","year":"1999","unstructured":"Flannery BA, Volpicelli JR, Pettinati HM (1999). Psychometric properties of the Penn Alcohol Craving Scale. Alcohol Clin Exp Res 23: 1289\u20131295.","journal-title":"Alcohol Clin Exp Res"},{"issue":"Suppl 1","key":"BFnpp201710_CR33","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.bbi.2011.01.005","volume":"25","author":"MG Frank","year":"2011","unstructured":"Frank MG, Watkins LR, Maier SF (2011). Stress- and glucocorticoid-induced priming of neuroinflammatory responses: potential mechanisms of stress-induced vulnerability to drugs of abuse. Brain Behav Immun 25 (Suppl 1): S21\u2013S28.","journal-title":"Brain Behav Immun"},{"key":"BFnpp201710_CR34","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s00213-014-3852-3","volume":"232","author":"KM Franklin","year":"2015","unstructured":"Franklin KM, Hauser SR, Lasek AW, McClintick J, Ding ZM, McBride WJ et al (2015). Reduction of alcohol drinking of alcohol-preferring (P) and high-alcohol drinking (HAD1) rats by targeting phosphodiesterase-4 (PDE4). Psychopharmacology (Berl) 232: 2251\u20132262.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201710_CR35","doi-asserted-by":"publisher","first-page":"e13417","DOI":"10.1371\/journal.pone.0013417","volume":"5","author":"C Giamp\u00e0","year":"2010","unstructured":"Giamp\u00e0 C, Laurenti D, Anzilotti S, Bernardi G, Menniti FS, Fusco FR (2010). Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6\/2 mouse model of Huntington's disease. PLoS ONE 5: e13417.","journal-title":"PLoS ONE"},{"key":"BFnpp201710_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejphar.2006.02.053","volume":"538","author":"LC Gibson","year":"2006","unstructured":"Gibson LC, Hastings SF, McPhee I, Clayton RA, Darroch CE, Mackenzie A et al (2006a). The inhibitory profile of Ibudilast against the human phosphodiesterase enzyme family. Eur J Pharmacol 538: 39\u201342.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp201710_CR37","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejphar.2006.02.053","volume":"538","author":"LCD Gibson","year":"2006","unstructured":"Gibson LCD, Hastings SF, McPhee I, Clayton RA, Darroch CE, Mackenzie A et al (2006b). The inhibitory profile of Ibudilast against the human phosphodiesterase enzyme family. Eur J Pharmacol 538: 39\u201342.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp201710_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.expneurol.2007.11.017","volume":"210","author":"J He","year":"2008","unstructured":"He J, Crews FT (2008). Increased MCP-1 and microglia in various regions of the human alcoholic brain. Exp Neurol 210: 349\u2013358.","journal-title":"Exp Neurol"},{"key":"BFnpp201710_CR39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.neubiorev.2009.11.018","volume":"35","author":"M Heilig","year":"2010","unstructured":"Heilig M, Thorsell A, Sommer WH, Hansson AC, Ramchandani VA, George DT et al (2010). Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues. Neurosci Biobehav Rev 35: 334\u2013344.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp201710_CR40","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1046\/j.1471-4159.2003.01748.x","volume":"85","author":"JG Hensler","year":"2003","unstructured":"Hensler JG, Ladenheim EE, Lyons WE (2003). Ethanol consumption and serotonin-1A (5-HT1A) receptor function in heterozygous BDNF (+\/-) mice. J Neurochem 85: 1139\u20131147.","journal-title":"J Neurochem"},{"key":"BFnpp201710_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.drugalcdep.2012.08.007","volume":"128","author":"AJ Herron","year":"2013","unstructured":"Herron AJ, Mariani JJ, Pavlicova M, Parrinello CM, Bold KW, Levin FR et al (2013). Assessment of riboflavin as a tracer substance: comparison of a qualitative to a quantitative method of riboflavin measurement. Drug Alcohol Depend 128: 77\u201382.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp201710_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3233\/JRS-160723","volume":"28","author":"S Hughes","year":"2016","unstructured":"Hughes S, Cohen D, Johnson R (2016). Adverse event assessment methods in published trials of psychotropic drugs: poor reporting and neglect of emerging safety concerns. Int J Risk Saf Med 28: 101\u2013114.","journal-title":"Int J Risk Saf Med"},{"key":"BFnpp201710_CR43","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.bbi.2008.09.012","volume":"23","author":"MR Hutchinson","year":"2009","unstructured":"Hutchinson MR, Lewis SS, Coats BD, Skyba DA, Crysdale NY, Berkelhammer DL et al (2009). Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast). Brain Behav Immun 23: 240\u2013250.","journal-title":"Brain Behav Immun"},{"key":"BFnpp201710_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bcp.2007.08.005","volume":"75","author":"BA Johnson","year":"2008","unstructured":"Johnson BA (2008). Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem Pharmacol 75: 34\u201356.","journal-title":"Biochem Pharmacol"},{"key":"BFnpp201710_CR45","doi-asserted-by":"publisher","first-page":"269","DOI":"10.4155\/cli.14.8","volume":"4","author":"KW Johnson","year":"2014","unstructured":"Johnson KW, Matsuda K, Iwaki Y (2014). Ibudilast for the treatment of drug addiction and other neurological conditions. Clin Invest 4: 269\u2013279.","journal-title":"Clin Invest"},{"issue":"Suppl 1","key":"BFnpp201710_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neuropharm.2008.07.043","volume":"56","author":"GF Koob","year":"2009","unstructured":"Koob GF (2009). Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 56 (Suppl 1): 18\u201331.","journal-title":"Neuropharmacology"},{"key":"BFnpp201710_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/B978-0-444-62619-6.00003-3","volume":"125","author":"GF Koob","year":"2014","unstructured":"Koob GF (2014). Neurocircuitry of alcohol addiction: synthesis from animal models. Handb Clin Neurol 125: 33\u201354.","journal-title":"Handb Clin Neurol"},{"key":"BFnpp201710_CR48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.biopsych.2015.10.024","volume":"80","author":"LE Kwako","year":"2016","unstructured":"Kwako LE, Momenan R, Litten RZ, Koob GF, Goldman D (2016). Addictions Neuroclinical Assessment: a neuroscience-based framework for addictive disorders. Biol Psychiatry 80: 179\u2013189.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201710_CR49","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/j.1360-0443.1987.tb00437.x","volume":"82","author":"JC Laberg","year":"1987","unstructured":"Laberg JC, Ellertsen B (1987). Psychophysiological indicators of craving in alcoholics: effects of cue exposure. Br J Addict 82: 1341\u20131348.","journal-title":"Br J Addict"},{"key":"BFnpp201710_CR50","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1517\/13543784.16.7.935","volume":"16","author":"A Ledeboer","year":"2007","unstructured":"Ledeboer A, Hutchinson MR, Watkins LR, Johnson KW (2007). Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes. Expert Opin Investig Drugs 16: 935\u2013950.","journal-title":"Expert Opin Investig Drugs"},{"key":"BFnpp201710_CR51","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1126\/science.8493557","volume":"260","author":"LF Lin","year":"1993","unstructured":"Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F (1993). GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260: 1130\u20131132.","journal-title":"Science"},{"key":"BFnpp201710_CR52","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0306-4603(90)90017-R","volume":"15","author":"MD Litt","year":"1990","unstructured":"Litt MD, Cooney NL, Kadden RM, Gaupp L (1990). Reactivity to alcohol cues and induced moods in alcoholics. Addict Behav 15: 137\u2013146.","journal-title":"Addict Behav"},{"key":"BFnpp201710_CR53","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1369-1600.2012.00454.x","volume":"17","author":"RZ Litten","year":"2012","unstructured":"Litten RZ, Egli M, Heilig M, Cui C, Fertig JB, Ryan ML et al (2012). Medications development to treat alcohol dependence: a vision for the next decade. Addict Biol 17: 513\u2013527.","journal-title":"Addict Biol"},{"key":"BFnpp201710_CR54","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1037\/a0035165","volume":"22","author":"MR Lofwall","year":"2014","unstructured":"Lofwall MR, Nuzzo PA, Campbell C, Walsh SL (2014). Aripiprazole effects on self-administration and pharmacodynamics of intravenous cocaine and cigarette smoking in humans. Exp Clin Psychopharmacol 22: 238\u2013247.","journal-title":"Exp Clin Psychopharmacol"},{"key":"BFnpp201710_CR55","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/npp.2014.20","volume":"39","author":"ML Logrip","year":"2014","unstructured":"Logrip ML, Vendruscolo LF, Schlosburg JE, Koob GF, Zorrilla EP (2014). Phosphodiesterase 10A regulates alcohol and saccharin self-administration in rats. Neuropsychopharmacology 39: 1722\u20131731.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201710_CR56","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/j.1530-0277.2006.00159.x","volume":"30","author":"J MacKillop","year":"2006","unstructured":"MacKillop J (2006). Factor structure of the alcohol urge questionnaire under neutral conditions and during a cue-elicited urge state. Alcohol Clin Exp Res 30: 1315\u20131321.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201710_CR57","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1530-0277.1993.tb00739.x","volume":"17","author":"CS Martin","year":"1993","unstructured":"Martin CS, Earleywine M, Musty RE, Perrine MW, Swift RM (1993). Development and validation of the Biphasic Alcohol Effects Scale. Alcohol Clin Exp Res 17: 140\u2013146.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201710_CR58","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/978-3-642-28720-6_201","volume":"13","author":"BJ Mason","year":"2013","unstructured":"Mason BJ, Higley AE (2013). A translational approach to novel medication development for protracted abstinence. Curr Top Behav Neurosci 13: 647\u2013670.","journal-title":"Curr Top Behav Neurosci"},{"key":"BFnpp201710_CR59","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.conb.2013.01.024","volume":"23","author":"J Mayfield","year":"2013","unstructured":"Mayfield J, Ferguson L, Harris RA (2013). Neuroimmune signaling: a key component of alcohol abuse. Curr Opin Neurobiol 23: 513\u2013520.","journal-title":"Curr Opin Neurobiol"},{"key":"BFnpp201710_CR60","doi-asserted-by":"publisher","first-page":"10542","DOI":"10.1523\/JNEUROSCI.3714-04.2004","volume":"24","author":"NN McGough","year":"2004","unstructured":"McGough NN, He DY, Logrip ML, Jeanblanc J, Phamluong K, Luong K et al (2004). RACK1 and brain-derived neurotrophic factor: a homeostatic pathway that regulates alcohol addiction. J Neurosci 24: 10542\u201310552.","journal-title":"J Neurosci"},{"key":"BFnpp201710_CR61","volume-title":"Manual for the Profile of Mood States","author":"DM McNair","year":"1971","unstructured":"McNair DM, Lorr M, Droppleman LF (1971) Manual for the Profile of Mood States. Educational & Industrial Testing Service: San Diego."},{"key":"BFnpp201710_CR62","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL (2009). Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65: 732\u2013741.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201710_CR63","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.neuropharm.2003.09.009","volume":"46","author":"T Mizuno","year":"2004","unstructured":"Mizuno T, Kurotani T, Komatsu Y, Kawanokuchi J, Kato H, Mitsuma N et al (2004). Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia. Neuropharmacology 46: 404\u2013411.","journal-title":"Neuropharmacology"},{"key":"BFnpp201710_CR64","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1038\/npp.2015.17","volume":"40","author":"M Moieni","year":"2015","unstructured":"Moieni M, Irwin MR, Jevtic I, Olmstead R, Breen EC, Eisenberger NI (2015). Sex differences in depressive and socioemotional responses to an inflammatory challenge: implications for sex differences in depression. Neuropsychopharmacology 40: 1709\u20131716.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201710_CR65","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1037\/0021-843X.96.2.122","volume":"96","author":"PM Monti","year":"1987","unstructured":"Monti PM, Binkoff JA, Abrams DB, Zwick WR, Nirenberg TD, Liepman MR (1987). Reactivity of alcoholics and nonalcoholics to drinking cues. J Abnorm Psychol 96: 122\u2013126.","journal-title":"J Abnorm Psychol"},{"key":"BFnpp201710_CR66","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1111\/j.1530-0277.2001.tb02170.x","volume":"25","author":"PM Monti","year":"2001","unstructured":"Monti PM, Rohsenow DJ, Swift RM, Gulliver SB, Colby SM, Mueller TI et al (2001). Naltrexone and cue exposure with coping and communication skills training for alcoholics: treatment process and 1-year outcomes. Alcohol Clin Exp Res 25: 1634\u20131647.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201710_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0079-6468(08)70302-3","volume":"33","author":"MN Palfreyman","year":"1996","unstructured":"Palfreyman MN, Souness JE (1996). Phosphodiesterase type IV inhibitors. Prog Med Chem 33: 1\u201352.","journal-title":"Prog Med Chem"},{"key":"BFnpp201710_CR68","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11920-011-0232-0","volume":"13","author":"CL Raison","year":"2011","unstructured":"Raison CL, Miller AH (2011). Is depression an inflammatory disorder? Curr Psychiatry Rep 13: 467\u2013475.","journal-title":"Curr Psychiatry Rep"},{"key":"BFnpp201710_CR69","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/j.1530-0277.2009.00906.x","volume":"33","author":"VA Ramchandani","year":"2009","unstructured":"Ramchandani VA, Plawecki M, Li TK, O'Connor S (2009). Intravenous ethanol infusions can mimic the time course of breath alcohol concentrations following oral alcohol administration in healthy volunteers. Alcohol Clin Exp Res 33: 938\u2013944.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201710_CR70","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1097\/01.ALC.0000148114.34000.B9","volume":"28","author":"LA Ray","year":"2004","unstructured":"Ray LA, Hutchison KE (2004). A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans. Alcohol Clin Exp Res 28: 1789\u20131795.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201710_CR71","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.2174\/138161210791516422","volume":"16","author":"LA Ray","year":"2010","unstructured":"Ray LA, Hutchison KE, Tartter M (2010). Application of human laboratory models to pharmacotherapy development for alcohol dependence. Curr Pharm Des 16: 2149\u20132158.","journal-title":"Curr Pharm Des"},{"key":"BFnpp201710_CR72","unstructured":"Rohn MCH, Lee MR, Kleuter SB, Schwandt ML, Falk DE, Leggio L (in press). Differences between Treatment-Seeking and Nontreatment-Seeking Alcohol Dependent Research Participants: an Exploratory Analysis. Alcohol Clin Exp Res."},{"key":"BFnpp201710_CR73","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1037\/0022-006X.62.3.620","volume":"62","author":"DJ Rohsenow","year":"1994","unstructured":"Rohsenow DJ, Monti PM, Rubonis AV, Sirota AD, Niaura RS, Colby SM et al (1994). Cue reactivity as a predictor of drinking among male alcoholics. J Consult Clin Psychol 62: 620\u2013626.","journal-title":"J Consult Clin Psychol"},{"key":"BFnpp201710_CR74","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/j.1365-2125.2008.03270.x","volume":"66","author":"P Rolan","year":"2008","unstructured":"Rolan P, Gibbons JA, He L, Chang E, Jones D, Gross MI et al (2008). Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses. Br J Clin Pharmacol 66: 792\u2013801.","journal-title":"Br J Clin Pharmacol"},{"key":"BFnpp201710_CR75","doi-asserted-by":"publisher","first-page":"487","DOI":"10.15288\/jsa.1994.55.487","volume":"55","author":"AV Rubonis","year":"1994","unstructured":"Rubonis AV, Colby SM, Monti PM, Rohsenow DJ, Gulliver SB, Sirota AD (1994). Alcohol cue reactivity and mood induction in male and female alcoholics. J Stud Alcohol 55: 487\u2013494.","journal-title":"J Stud Alcohol"},{"key":"BFnpp201710_CR76","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1369-1600.2008.00134.x","volume":"14","author":"R Sinha","year":"2009","unstructured":"Sinha R (2009). Modeling stress and drug craving in the laboratory: implications for addiction treatment development. Addict Biol 14: 84\u201398.","journal-title":"Addict Biol"},{"key":"BFnpp201710_CR77","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1038\/npp.2008.78","volume":"34","author":"R Sinha","year":"2009","unstructured":"Sinha R, Fox HC, Hong KA, Bergquist K, Bhagwagar Z, Siedlarz KM (2009). Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharmacology 34: 1198\u20131208.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp201710_CR78","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s002130000499","volume":"152","author":"R Sinha","year":"2000","unstructured":"Sinha R, Fuse T, Aubin LR, O'Malley SS (2000). Psychological stress, drug-related cues and cocaine craving. Psychopharmacology (Berl) 152: 140\u2013148.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201710_CR79","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/00006842-199207000-00005","volume":"54","author":"R Sinha","year":"1992","unstructured":"Sinha R, Lovallo WR, Parsons OA (1992). Cardiovascular differentiation of emotions. Psychosom Med 54: 422\u2013435.","journal-title":"Psychosom Med"},{"key":"BFnpp201710_CR80","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","volume":"84","author":"JT Sullivan","year":"1989","unstructured":"Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM (1989). Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84: 1353\u20131357.","journal-title":"Br J Addict"},{"key":"BFnpp201710_CR81","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0006-8993(99)01666-2","volume":"837","author":"A Suzumura","year":"1999","unstructured":"Suzumura A, Ito A, Yoshikawa M, Sawada M (1999). Ibudilast suppresses TNFa production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS. Brain Res 837: 203\u2013212.","journal-title":"Brain Res"},{"key":"BFnpp201710_CR82","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0165-6147(97)01049-3","volume":"18","author":"MM Teixeira","year":"1997","unstructured":"Teixeira MM, Gristwood RW, Cooper N, Hellewell PG (1997). Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future? Trends Pharmacol Sci 18: 164\u2013171.","journal-title":"Trends Pharmacol Sci"},{"key":"BFnpp201710_CR83","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1111\/j.1530-0277.2012.01845.x","volume":"36","author":"RT Wen","year":"2012","unstructured":"Wen RT, Zhang M, Qin WJ, Liu Q, Wang WP, Lawrence AJ et al (2012). The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring fawn-hooded rats. Alcohol Clin Exp Res 36: 2157\u20132167.","journal-title":"Alcohol Clin Exp Res"},{"key":"BFnpp201710_CR84","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.drugalcdep.2016.02.036","volume":"162","author":"MJ Worley","year":"2016","unstructured":"Worley MJ, Heinzerling KG, Roche DJ, Shoptaw S (2016). Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study. Drug Alcohol Depend 162: 245\u2013250.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp201710_CR85","doi-asserted-by":"publisher","first-page":"S155","DOI":"10.1016\/j.bbi.2011.01.012","volume":"25","author":"Y Wu","year":"2011","unstructured":"Wu Y, Lousberg EL, Moldenhauer LM, Hayball JD, Robertson SA, Coller JK et al (2011). Attenuation of microglial and IL-1 signaling protects mice from acute alcohol-induced sedation and\/or motor impairment. Brain Behav Immun 25: S155\u2013S164.","journal-title":"Brain Behav Immun"},{"key":"BFnpp201710_CR86","unstructured":"Yardley MM, Ray LA (2016). Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models. Addict Biol."}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp201710.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201710","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/npp.2017.10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/npp201710.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T14:23:49Z","timestamp":1749911029000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp201710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,16]]},"references-count":86,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["BFnpp201710"],"URL":"https:\/\/doi.org\/10.1038\/npp.2017.10","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,16]]},"assertion":[{"value":"27 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}